Skip to main content
Top
Published in: BMC Medicine 1/2015

Open Access 01-12-2015 | Commentary

Opening clinical trial data: are the voluntary data-sharing portals enough?

Authors: Nophar Geifman, Jennifer Bollyky, Sanchita Bhattacharya, Atul J. Butte

Published in: BMC Medicine | Issue 1/2015

Login to get access

Abstract

Data generated by the numerous clinical trials conducted annually worldwide have the potential to be extremely beneficial to the scientific and patient communities. This potential is well recognized and efforts are being made to encourage the release of raw patient-level data from these trials to the public. The issue of sharing clinical trial data has recently gained attention, with many agreeing that this type of data should be made available for research in a timely manner. The availability of clinical trial data is most important for study reproducibility, meta-analyses, and improvement of study design. There is much discussion in the community over key data sharing issues, including the risks this practice holds. However, one aspect that remains to be adequately addressed is that of the accessibility, quality, and usability of the data being shared. Herein, experiences with the two current major platforms used to store and disseminate clinical trial data are described, discussing the issues encountered and suggesting possible solutions.
Literature
1.
go back to reference Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington, DC: The National Academies Press; 2015. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. Washington, DC: The National Academies Press; 2015.
2.
go back to reference Rosenblatt M, Jain SH, Cahill M. Sharing of clinical trial data: benefits, risks, and uniform principles. Ann Intern Med. 2015;162(4):306–7.CrossRefPubMed Rosenblatt M, Jain SH, Cahill M. Sharing of clinical trial data: benefits, risks, and uniform principles. Ann Intern Med. 2015;162(4):306–7.CrossRefPubMed
3.
go back to reference Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013;369(5):475–8.CrossRefPubMed Nisen P, Rockhold F. Access to patient-level data from GlaxoSmithKline clinical trials. N Engl J Med. 2013;369(5):475–8.CrossRefPubMed
4.
go back to reference Hede K. Project data sphere to make cancer clinical trial data publicly available. J Natl Cancer Inst. 2013;105(16):1159–60.CrossRefPubMed Hede K. Project data sphere to make cancer clinical trial data publicly available. J Natl Cancer Inst. 2013;105(16):1159–60.CrossRefPubMed
5.
go back to reference Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, Pontius J, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2–3):234–9.CrossRefPubMed Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, Pontius J, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2–3):234–9.CrossRefPubMed
6.
go back to reference Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30(11):2133–45.CrossRefPubMed Milne CP, Bruss JB. The economics of pediatric formulation development for off-patent drugs. Clin Ther. 2008;30(11):2133–45.CrossRefPubMed
Metadata
Title
Opening clinical trial data: are the voluntary data-sharing portals enough?
Authors
Nophar Geifman
Jennifer Bollyky
Sanchita Bhattacharya
Atul J. Butte
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2015
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-015-0525-y

Other articles of this Issue 1/2015

BMC Medicine 1/2015 Go to the issue